Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-Sequencing of HepG2 cells treated with TGFBeta

ABSTRACT: RNA-Sequencing of HepG2 cells treated with TGFBeta

PROVIDER: PRJNA578102 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR10300808_1.fastq.gz	Fastqsanger.gz
	SRR10300808_2.fastq.gz	Fastqsanger.gz
	SRR10300809_1.fastq.gz	Fastqsanger.gz
	SRR10300809_2.fastq.gz	Fastqsanger.gz
	SRR10300810_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

RNA-Sequencing of HepG2 cells treated with TGFBeta

Project description:We report a subset of genes upregulated by TGFBeta after three hours of treatment

2019-10-18 | GSE139021 | GEO

cholangiocytes treated with TGFbeta

Project description:cholangiocytes treated with TGFbeta

| PRJNA606515 | ENA

Expression data from TGFbeta-treated control or aPKC silenced A549 cells

Project description:Aberrant TGFbeta signalling is a hallmark of epithelial derived tumours. Signalling patterns can depend on the membrane trafficking and internalization of the TGFbeta receptors. Protein kinase C (PKC), particularly the atypical PKC isoforms, alter the trafficking of TGFbeta receptors and can alter TGFbeta induced gene expression. We used microarrays to detail the programme of gene expression underlying TGFbeta induction between control or aPKC silenced A549 cells. Control or aPKC silenced A549 cells were serum starved and treated with TGFbeta for 1 hour. Total RNA was extracted from untreated or TGFbeta treated cells after 8 and 24 hours and analyzed using Affymetrix microarrays. We sought to assess TGFbeta gene expression in aPKC silenced lung cancer cells, as we found that knockdown of aPKC extends TGFbeta signalling as assessed by phospho Smad2 levels. Furthermore, increased expression and oncogenic activity of aPKC (PKCiota) has been reported in lung cancer cells.

2011-01-29 | E-GEOD-26241 | biostudies-arrayexpress

RNA-sequencing analysis of HepG2 cells treated with atorvastatin.

Project description:The cholesterol-lowering drug atorvastatin is among the most prescribed drug in the world. Alternative splicing in a number of genes has been reported to be associated with variable statin response. RNA-seq has proven to be a powerful technique for genome-wide splice variant analysis. In the present study, we sought to investigate atorvastatin responsive splice variants in HepG2 cells using RNA-seq analysis to identify novel candidate genes implicated in cholesterol homeostasis and in the statin response. HepG2 cells were treated with 10 µM atorvastatin for 24 hours. RNA-seq and exon array analyses were performed. The validation of selected genes was performed using Taqman gene expression assays. RNA-seq analysis identified 121 genes and 98 specific splice variants, of which four were minor splice variants to be differentially expressed, 11 were genes with potential changes in their splicing patterns (SYCP3, ZNF195, ZNF674, MYD88, WHSC1, KIF16B, ZNF92, AGER, FCHO1, SLC6A12 and AKAP9), and one was a gene (RAP1GAP) with differential promoter usage. The IL21R transcript was detected to be differentially expressed via RNA-seq and RT-qPCR, but not in the exon array. In conclusion, several novel candidate genes that are affected by atorvastatin treatment were identified in this study. Further studies are needed to determine the biological significance of the atorvastatin responsive splice variants that have been uniquely identified using RNA-seq.

| S-EPMC4143339 | biostudies-literature

ChIP-seq of cholangiocytes treated with TGFbeta

Project description:ChIP-seq of cholangiocytes treated with TGFbeta

| PRJNA606517 | ENA

ATAC-seq of cholangiocytes treated with TGFbeta

Project description:ATAC-seq of cholangiocytes treated with TGFbeta

| PRJNA606518 | ENA

RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist

Project description:RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist

| PRJNA449680 | ENA

RNA-Sequencing of HepG2 cells treated with Chinese herbal medicine Pulsatilla Chinensis

Project description:RNA-Sequencing of HepG2 cells treated with Chinese herbal medicine Pulsatilla Chinensis